Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 402

1.

Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.

Panidis IP, Morganroth J, Baessler C.

Am J Cardiol. 1983 Dec 1;52(10):1197-201.

PMID:
6359848
[PubMed - indexed for MEDLINE]
2.

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.

Waxman HL, Myerburg RJ, Appel R, Sung RJ.

Ann Intern Med. 1981 Jan;94(1):1-6.

PMID:
7447203
[PubMed - indexed for MEDLINE]
3.

Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study.

Lang R, Klein HO, Di Segni E, Gefen J, Sareli P, Libhaber C, David D, Weiss E, Guerrero J, Kaplinsky E.

Am Heart J. 1983 May;105(5):820-5.

PMID:
6846125
[PubMed - indexed for MEDLINE]
4.

[Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].

Vitale P, Auricchio A, De Stefano R, Agretto A, De Simone R, Vitale N, Barbato F, Iacono A.

Cardiologia. 1989 Jan;34(1):73-81. Italian.

PMID:
2720716
[PubMed - indexed for MEDLINE]
5.

Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil.

Tommaso C, McDonough T, Parker M, Talano JV.

Arch Intern Med. 1983 May;143(5):877-81.

PMID:
6679229
[PubMed - indexed for MEDLINE]
6.

Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.

DiBianco R, Morganroth J, Freitag JA, Ronan JA Jr, Lindgren KM, Donohue DJ, Larca LJ, Chadda KD, Olukotun AY.

Am Heart J. 1984 Oct;108(4 Pt 2):1121-7.

PMID:
6148872
[PubMed - indexed for MEDLINE]
7.

Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.

Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL.

Pharmacotherapy. 1997 Nov-Dec;17(6):1238-45.

PMID:
9399606
[PubMed - indexed for MEDLINE]
8.

Treatment of supraventricular arrhythmias with intravenous and oral verapamil.

Gonzalez R, Scheinman MM.

Chest. 1981 Oct;80(4):465-70.

PMID:
7023864
[PubMed - indexed for MEDLINE]
9.

Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.

Platia EV, Michelson EL, Porterfield JK, Das G.

Am J Cardiol. 1989 Apr 15;63(13):925-9.

PMID:
2564725
[PubMed - indexed for MEDLINE]
10.

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.

Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA.

Am Heart J. 1995 Apr;129(4):739-48.

PMID:
7900626
[PubMed - indexed for MEDLINE]
11.

Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.

Pomfret SM, Beasley CR, Challenor V, Holgate ST.

Clin Sci (Lond). 1988 Apr;74(4):351-7.

PMID:
3281786
[PubMed - indexed for MEDLINE]
12.

Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.

Subramanian VB, Bowles MJ, Davies AB, Raftery EB.

Am J Cardiol. 1982 Nov;50(5):1158-63.

PMID:
6127945
[PubMed - indexed for MEDLINE]
13.

Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.

Innes GD, Vertesi L, Dillon EC, Metcalfe C.

Ann Emerg Med. 1997 Jan;29(1):126-34.

PMID:
8998091
[PubMed - indexed for MEDLINE]
14.

Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.

Lewis RV, McMurray J, McDevitt DG.

J Cardiovasc Pharmacol. 1989 Jan;13(1):1-6.

PMID:
2468920
[PubMed - indexed for MEDLINE]
15.

Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.

Atwood JE, Sullivan M, Forbes S, Myers J, Pewen W, Olson HG, Froelicher VF.

J Am Coll Cardiol. 1987 Aug;10(2):314-20.

PMID:
2885354
[PubMed - indexed for MEDLINE]
16.

Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.

Matsuda M, Matsuda Y, Yamagishi T, Takahashi T, Haraguchi M, Tada T, Kusukawa R.

Cardiovasc Res. 1991 Jun;25(6):453-7.

PMID:
1889058
[PubMed - indexed for MEDLINE]
17.

A comparison of verapamil and digoxin in the treatment of atrial fibrillation.

Lewis R, Lakhani M, Moreland TA, McDevitt DG.

Eur Heart J. 1987 Feb;8(2):148-53.

PMID:
3552680
[PubMed - indexed for MEDLINE]
18.

[Antiarrhythmic effects of verapamil].

Shapiro M, Malo R, Férez S, Martínez-Ríos MA, Salazar E.

Arch Inst Cardiol Mex. 1976 May-Jun;46(3):305-16. Spanish.

PMID:
1088854
[PubMed - indexed for MEDLINE]
19.

A randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardia.

Arsura E, Lefkin AS, Scher DL, Solar M, Tessler S.

Am J Med. 1988 Oct;85(4):519-24. Erratum in: Am J Med 1989 Jan;86(1):142.

PMID:
3052051
[PubMed - indexed for MEDLINE]
20.

Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation.

Lundström T, Moor E, Rydén L.

Am Heart J. 1992 Oct;124(4):917-23.

PMID:
1356311
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk